DNA Sequencing Market is Segmented By Product Type (Instruments, Consumables, Other), By Sequencing Type (Next-Generation Sequencing, Sanger Sequencing, Other), By Application (Diagnostics, Personalized Medicine, Other), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2024-2031.
DNA Sequencing Market is expected to grow at a CAGR 11.3% during the forecast period (2024-2031).
The procedure of determining or identifying the sequence of nucleotides within a DNA molecule is known as DNA sequencing. Scientists can use it to sequence genes and genomes. Scientists can obtain information about mutations that cause disease after identifying and analyzing the genes based on sequence information, providing significant medical information.
DNA Sequencing Market Scope
Metrics |
Details |
Market CAGR |
11.3% |
Segments Covered |
By Product Type, By Sequencing Type, By Application, and By Region |
Report Insights Covered |
Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other key insights. |
Fastest Growing Region |
Asia Pacific |
Largest Market Share |
North America |
DNA Sequencing Market Dynamics
The factors driving the global DNA sequencing market are the increasing technological advancements are expected to drive market growth.
The increasing technological advancements are expected to drive the market growth in the forecast period
From 2D sequencing to DNA sequencing, technological advances in sequencing have come a long way. Platforms such as Illumina/Solexa, ABI/SOLiD, 454/Roche, and Helicos have provided unique opportunities for high-throughput functional genomics research in recent years. Furthermore, biologists and informatics experts have been focusing on developing better genomes, which has been made possible by newer sequencing technologies, novel methods for locating sequences on chromosomes, and improved DNA sequencing software. Modern research in many scientific fields heavily relies on DNA analysis to investigate hypotheses at the genetic and genomic levels. With such a strong reliance on these technologies, it is no surprise that the field of genetic analysis is rapidly advancing and producing more effective and efficient technologies and methods ever. Following the huge success of the Human Genome Project's Sanger sequencing technology, Second Generation Sequencing (SGS) techniques have evolved rapidly. These methods have much higher throughput and, as a result, a lower cost per sequenced base. Furthermore, with the pandemic of COVID-19 infection, next-generation sequencing (NGS) technology is gaining popularity as a routine clinical diagnostic test, which positively impacts the market.
The problems associated with DNA sequencing is expected to hamper the market growth
The function of most of the genes in the human genome is still unknown or only partially understood. As a result, much of the "information" found in a human genome sequence is currently useless. Most physicians are not trained to interpret genomic data. A person's genome may contain information about them that they do not want to know. For instance, a patient may undergo genome sequencing to determine the most effective treatment plan for high cholesterol. Researchers discover an unrelated allele that ensures a terminal disease with no effective treatment during the process. A genome sequence contains a massive amount of information. Policies and security measures to ensure the privacy and security of this information are still in the works. Hence, the DNA sequencing market is expected to hamper.
COVID-19 Impact Analysis
The pandemic of COVID-19 has positively impacted the market due to the increasing demand for DNA sequencing technology in the development of diagnostics and therapeutics. For instance, the FDA authorized the Helix COVID-19 NGS test for use only by Helix Laboratory under an Emergency Use Authorization (EUA) in August 2020; it is an amplicon-based next-generation sequencing (NGS) test intended for the qualitative detection of nucleic acid from SARS-CoV-2 in upper respiratory specimens from individuals suspected of COVID-19. As a result of the increased DNA sequencing-based research and development activities in developing diagnostic tools or effective COVID-19 therapeutics, the market is expected to maintain its significant growth rate during the forecast period.
DNA Sequencing Market Segment Analysis
The Next-generation sequencing segment is expected to drive the market growth in the forecast period
Factors such as the increasing applications of NGS, speed, cost, accuracy, efficient replacement of traditional technologies, and drug discovery applications requiring NGS technology are driving the next-generation sequencing segment. The advantage of this technology is that it is significantly cheaper, faster, and requires significantly less DNA, which aids in the segment's overall growth.
Because of the COVID-19 pandemic, there has been an increase in the use of next-generation sequencing technology in infection diagnostics, owing to its high efficiency and accuracy. The FDA granted Ilumina Inc. an emergency use authorization for the COVIDSeq Test, the first COVID-19 diagnostic test utilizing next-generation sequence technology, in June 2020. The benefit of using a next-generation sequencing test is that it generates information about the genomic sequence of the virus present in a sample and detects the virus's presence in the sample. This genomic information can also be used for research. Along with the benefits and growing demand for this technology, the launches and advancements significantly contribute to the segment's growth. For instance, on November 6th, 2019, Thermo Fisher Scientific introduced the Ion Torrent Genexus System, the first fully-integrated next-generation sequencing (NGS) platform with an automated specimen-to-report workflow that delivers results economically a single day. As a result, this segment is expected to dominate the market during the forecast period.
DNA Sequencing Market Geographical Analysis
North America region is expected to hold the largest market share in the global DNA sequencing market
The increase in government and non-government funding and support activities, particularly in the United States, and the increasing adoption of advanced technologies are expected to drive the DNA sequencing market in the country.
The rising COVID-19 pandemic is having a positive impact on market growth. For instance, in April 2020, Genome Canada launched the Canadian COVID Genomics Network (CanCOGeN), a newly formed initiative supported by USD 40 million in funding. CanCOGeN, led by Genome Canada, will scale up genomics-based COVID-19 research in Canada in collaboration with the six regional Genome Centers, national and provincial public health labs, genome sequencing centers through CGEn, hospitals, universities, and the private sector.
DNA Sequencing Market Competitive Landscape
The global DNA sequencing market is highly competitive with mergers, collaborations, and product launches. Some of the key players in the market are Agilent Technologies Inc., Bio-Rad Laboratories Inc., Danaher Corporation, Eurofins Scientific, F. Hoffmann-La Roche, Illumina Inc., Merck KGaA, Pacific Biosciences of California Inc., PerkinElmer Inc., and Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc.
Overview: Thermo Fisher Scientific is based in the United States that sells scientific
instruments, reagents and consumables, and software services. Waltham, Massachusetts, is
the company’s headquarters. The company was founded in 1956.
Product Portfolio: The Ion Torrent Genexus System automatically performs sample and library preparation, sequencing, analysis, and reporting. The Genexus Purification System and Genexus Integrated Sequencer with Genexus Software work in unison, automatically tracking sample information and results throughout the process. This automated system eliminates manual steps while providing high-quality data and timely reports.
Key Developments: On November 6th, 2019, Thermo Fisher Scientific launched the Ion Torrent Genexus System, the first fully integrated next-generation sequencing (NGS) platform with an automated specimen-to-report workflow that delivers results economically in a single day.
Frequently Asked Questions
What is the Projected CAGR value of the DNA Sequencing Market?
DNA Sequencing Market is expected to grow at a CAGR of 11.3% during the forecasting period 2024-2031.
Which region controlled the global market during 2024-2031?
North America region Controls the DNA Sequencing Market during 2024-2031
Which is the fastest growing region in the DNA Sequencing Market?
Among all regions, Asia Pacific is the fastest growing market share during the forecast period.